SGLT2 inhibitors offer particular benefits in heart failure (HF) and CKD, while GLP-1 RAs are particularly effective in reducing ischemic events and weight loss, with improvement in metabolic parameters
They offer lozenges, tablets, pills, cheek gels, drops, and dissolving strips, promising to deliver the same active ingredients as the trademark medications without the injections
The Verdict Who Should Consider the Pill
et al., 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes, European Heart Journal 2023
Designed for adults with obesity or overweight individuals with weight-related complications, this oral option mimics natural hormones to regulate appetite and reduce cravings
Naunyn Schmiedeb